The Life Sciences Report: You are a boutique firm. What kind of flexibility does that give you, and how does that translate to your clients’ benefit? Steve Brozak: We are an independent full-service broker-dealer, and we have a distribution system of independent brokers who are not wed to any product or product mix. Our size gives us the flexibility to take advantage of any opportunities that come up. We can be just as competitive as the bulge-bracket firms in a lot of categories, but at the same time we are able to screen down to a small number of candidates to write research on. We can filter the … [visit site to read . . . → Read More: Make Friends with Companion Diagnostics to Bolster Your Biotech Portfolio: Stephen Brozak